The power of precision medicine in cancer drug discovery and treatment 14 Mar 2018 Dr Olivia Rossanese is finding new ways to target cancer with drugs and previously, at GlaxoSmithKline, was in the team that discovered the targeted cancer treatment, and BRAF inhibitor, dabrafenib. Our Communications Administrator, Tilly Haynes, heard what she had to say about the future of precision medicine at The Economist’s ‘War on Cancer’ event. Find out more Show/Hide